#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15120	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2496	745.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1610	1610	C	905	C,G,T	902,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15120	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2496	745.5	0	HET	.	.	.	C1450T,G	.	1450	1450	C	1876	1876	C	1001	C,T,G	781,219,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25696	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4173	769.0	0	.	n	.	0	T695C	SNP	695	695	T	1310	1310	C	962	C,G,A	960,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25696	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4173	769.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1952	1952	A	1000	A,G,C	746,252,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25696	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4173	769.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2586	2586	C	901	C,G	900,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25696	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4173	769.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2660	2660	A	823	A	823	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25696	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4173	769.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3212	3212	C	972	C	971	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25696	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4173	769.0	0	HET	.	.	.	C76CGGGGG,CGGGG	.	76	76	C	691	691	C	931	CGGGGG,CGGGG	664,215	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2238	folP	855	855	100.0	folP.l15.c4.ctg.1	2130	131.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1373	1375	AGC	213;211;212	A,G;G;C	211,2;211;212	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5110	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3967	160.8	1	SNP	p	S91F	1	.	.	271	273	TTC	901	903	TTC	207;207;209	T;T;C	207;207;209	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5110	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3967	160.8	1	SNP	p	D95N	0	.	.	283	285	GAC	913	915	GAC	227;228;228	G;A;C	227;228;228	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5110	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3967	160.8	1	SNP	p	D95G	0	.	.	283	285	GAC	913	915	GAC	227;228;228	G;A;C	227;228;228	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1978	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1852	133.2	1	SNP	p	G45D	1	.	.	133	135	GAC	754	756	GAC	228;229;228	G;A;C,G	228;229;226,2	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1138	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1381	102.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4962	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3418	181.3	1	SNP	p	D86N	0	.	.	256	258	GAC	775	777	GAC	243;245;245	G;A,C;C	243;244,1;245	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4962	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3418	181.3	1	SNP	p	S87R	0	.	.	259	261	AGT	778	780	AGT	244;244;240	A;G;T,G	244;244;239,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4962	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3418	181.3	1	SNP	p	S87W	0	.	.	259	261	AGT	778	780	AGT	244;244;240	A;G;T,G	244;244;239,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4962	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3418	181.3	1	SNP	p	S87I	0	.	.	259	261	AGT	778	780	AGT	244;244;240	A;G;T,G	244;244;239,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4962	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3418	181.3	1	SNP	p	S88P	0	.	.	262	264	TCC	781	783	TCC	241;240;241	T;C,T;C,A	241;239,1;240,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4118	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3037	169.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1753	1755	GGC	220;222;222	G;G;C,T	220;222;221,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1480	1482	GCA	249;251;252	G;C;A	249;251;252	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1483	1485	ATC	253;248;247	A;T,C;C,T	253;247,1;246,1	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1495	1497	GTG	249;248;249	G;T;G	249;248;249	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1495	1497	GTG	249;248;249	G;T;G	249;248;249	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1999	2001	ACC	234;233;233	A,T;C;C	233,1;233;233	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2053	2055	GCG	216;216;215	G,T;C,G,T;G,A	215,1;214,1,1;214,1	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2053	2055	GCG	216;216;215	G,T;C,G,T;G,A	215,1;214,1,1;214,1	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2176	2178	AGC	244;244;244	A;G;C	244;244;244	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2185	2187	GGC	243;239;242	G;G,C;C	243;238,1;242	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3940	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	170.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2203	2205	CCG	243;247;244	C,G;C,A;G,C	242,1;246,1;243,1	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5436	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3645	186.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1922	1924	CCG	226;225;223	C;C,G;G	226;224,1;223	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2272	porA	1146	1146	99.56	porA.l15.c17.ctg.1	2393	118.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	665	667	GGC	152;151;153	G;G;C,T	152;151;152,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2272	porA	1146	1146	99.56	porA.l15.c17.ctg.1	2393	118.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	847	847	C	163	C,A	162,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	422	424	AAT	20;20;20	A;A;T	20;20;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	425	427	AAT	20;20;20	A;A;T	20;20;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	449	451	GCA	17;17;17	G;C;A	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	472	474	GTA	17;17;17	G;T;A	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	S236N	NONSYN	706	708	AGC	478	480	AAC	17;17;17	A;A;C	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	.	MULTIPLE	709	711	AAC	482	486	TGGCG	17;17;17;17;17	T;G;G;C;G	17;17;17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	D238A	NONSYN	712	714	GAT	488	490	GCT	17;17;17	G;C;T	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	A251V	NONSYN	751	753	GCG	527	529	GTA	26;26;27	G;T;A	26;26;27	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	587	589	ACT	78;78;78	A,T;C;T,G	77,1;78;77,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	593	595	GAT	78;78;78	G,T;A;T	77,1;78;78	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	D276N	NONSYN	826	828	GAT	602	604	AAC	78;78;78	A,G;A;C,T	77,1;78;77,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	346	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	689	31.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	605	607	CAC	78;78;78	C,A;A;C	77,1;78;78	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2742	porB1b	1041	1041	99.04	porB1b.l6.c4.ctg.1	2101	162.9	0	.	p	.	0	S36Y	NONSYN	106	108	TCT	664	666	TAT	170;172;171	T,C;A;T	169,1;172;171	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2742	porB1b	1041	1041	99.04	porB1b.l6.c4.ctg.1	2101	162.9	0	.	p	.	0	K120D	NONSYN	358	360	AAG	916	918	GAC	228;228;230	G;A;C	228;228;230	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2742	porB1b	1041	1041	99.04	porB1b.l6.c4.ctg.1	2101	162.9	0	.	p	.	0	K208del	DEL	622	622	A	1179	1179	A	227	A	227	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2742	porB1b	1041	1041	99.04	porB1b.l6.c4.ctg.1	2101	162.9	0	.	p	.	0	G211S	NONSYN	631	633	GGC	1186	1188	AGC	225;225;223	A;G;C	225;225;223	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2742	porB1b	1041	1041	99.04	porB1b.l6.c4.ctg.1	2101	162.9	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1201	1203	ATC	235;233;233	A;T,G;C	235;232,1;233	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2742	porB1b	1041	1041	99.04	porB1b.l6.c4.ctg.1	2101	162.9	0	.	p	.	0	I333T	NONSYN	997	999	ATC	1552	1554	ACC	215;213;212	A;C,T;C,A	215;212,1;211,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9648	rpoB	4179	4179	99.95	rpoB.l15.c17.ctg.1	5405	223.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1448	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1519	119.1	1	SNP	p	V57M	1	.	.	169	171	ATG	790	792	ATG	268;272;270	A;T,C;G	268;271,1;270	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
